Kamagra Super (sildenafil + dapoxetine)
Kamagra Super (sildenafil + dapoxetine): explicit RSM supplier evidence, exact component/formulation context and the limits of manufacturer and clinical attribution.
- Active ingredients
- Sildenafil + Dapoxetine
- Form
- Tablet
- Listing company
- RSM Enterprises
Super Kamagra is listed by RSM Enterprises as sildenafil 100 mg plus dapoxetine 60 mg. That is a documented supplier listing for the combination name. It does not independently establish Ajanta as manufacturer of this exact product, even though plain Kamagra has an Ajanta association in the pharmacy evidence.
The added ingredient is the important change
Plain Kamagra is a sildenafil family. Super Kamagra adds dapoxetine, so it addresses a separate ejaculation-control question as well as erection response. It should not be interpreted as simply a more powerful Kamagra tablet.
A printed total such as 160 mg can combine 100 mg sildenafil with 60 mg dapoxetine. It is not 160 mg sildenafil, nor a statement that the whole tablet has one interchangeable pharmacological strength.
Identity evidence is not a clinical trial
The RSM listing identifies the offered name and composition. Ingredient labels explain interactions, but do not establish this fixed formulation’s equivalence, authorization or clinical performance. A familiar “Kamagra” prefix does not close those gaps.
There is selected-patient research on adding dapoxetine to an established PDE5 regimen, alongside regional label restrictions on co-use. The ED and PE guide explains why that evidence needs the patient’s context and a matching product record. Other antidepressants, occasional ED treatment and cardiovascular medicines all belong in the review before a combined product is considered.
Product record
- Company
- RSM Enterprises supplier listing; Ajanta manufacture not independently confirmed
- Strengths listed
- Sildenafil 100 mg + dapoxetine 60 mg (RSM listing)
- Treatment area
- Erectile dysfunction (ED); Premature ejaculation (PE)
- Identity
- Exact product name and composition have a supplier listing; factory/local authorization need separate confirmation
- Record reviewed
- 4 October 2026; source retrieval dates are retained with the evidence
Listed strengths identify a product; they are not dosing advice. A listing in one country does not show that a product is authorized where you live.
About sildenafil
Sildenafil supports the erection response to stimulation. Food can delay absorption of ordinary film-coated tablets; blood half-life is not a guaranteed response window. Timed follow-up can help explain an apparent nonresponse.
About dapoxetine
Dapoxetine has defined regional PE indications and on-demand trial evidence. Control and distress matter as well as measured minutes. Fainting, alcohol and interacting medicines need review; standalone evidence does not validate every ED/PE combination.
About unverified names
This profile has historical, supplier or incomplete identity evidence. Some names have a company catalogue association; others have secondary listings with unresolved details. Read the exact source and remaining gap rather than assuming every unfamiliar name has no company evidence.
About fixed combinations
A fixed combination puts two medicines in one tablet at set doses. Each ingredient brings its own side effects and interactions, and approval of each ingredient on its own does not mean the combination is approved or suitable.
Do not add another ED or PE medicine to a combination product.
Using a PDE5 inhibitor safely
Never take a PDE5 inhibitor with nitrates, recreational nitrites (“poppers”) or riociguat, and do not combine two ED medicines. Seek urgent medical help for chest pain, an erection lasting more than four hours, or sudden loss of vision or hearing.
Common side effects include headache, flushing, indigestion and a blocked nose.
Sources
3 sources
Checked .
- Kamagra Super (sildenafil + dapoxetine) supplier listing — RSM Enterprises
- VIAGRA (sildenafil) US prescribing information — DailyMed, US National Library of Medicine. Ingredient reference; it does not describe this brand.
- Priligy (dapoxetine 30 mg) Australian register entry — Therapeutic Goods Administration (Australia). Ingredient reference; it does not describe this brand.